Article
Using deep learning to identify bladder cancers with FGFR-activating mutations from histology images.
Cancer medicine - 1 Jul 2021
Velmahos Constantine S, Badgeley Marcus, Lo Ying-Chun
Abstract excerpt
BACKGROUND: In recent years, the fibroblast growth factor receptor (FGFR) pathway has been proven to be an important therapeutic target in bladder cancer. FGFR-targeted therapies are effective for patients with FGFR mutation, which can be discovered through genetic sequencing. However, genetic sequencing is not commonly performed at diagnosis, whereas a histologic assessment of the tumor is. We aim to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
